Plasmablastic cytomorphologic features in plasma cell neoplasms in immunocompetent patients are significantly associated with EBV

American Journal of Clinical Pathology

Volumn 128, Issue 2, 2007, Pages 339-344

  Chang, Sheng Tsung ^a   Liao, Yung Liang ^a   Lu, Chin Li ^a   Chuang, Shih Sung ^a,b   Li, Chin Yang ^c  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c MAYO CLINIC   (United States)

Author keywords

EBV; Epstein Barr virus; Multiple myeloma; Plasma cell myeloma; Plasmablastic lymphoma; Plasmacytoma

Indexed keywords

MELPHALAN; PREDNISOLONE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CELL PROLIFERATION; CELL STRUCTURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PLASMACYTOMA; PRIORITY JOURNAL;

ADULT; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PLASMACYTOMA; RNA, VIRAL;

EID: 34547870578     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/27H8XJH31F3GUNAT     Document Type: Article

References (29)

1. Voelkerding KV, Sandhaus LM, Kim HC, et al. Plasma cell malignancy in the acquired immune deficiency syndrome: association with Epstein-Barr virus. Am J Clin Pathol. 1989;92:222-228.
2. Peniket AJ, Perry AR, Williams CD, et al. A case of EBV-associated lymphoproliferative disease following high-dose therapy and CD34-purified autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant. 1998;22:307-309.
3. Papadaki HA, Stefanaki K, Kanavaros P, et al. Epstein-Barr virus-associated high-grade anaplastic plasmacytoma in a renal transplant patient. Leuk Lymphoma. 2000;36:411-415.
4. Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood. 1997;89:1413-1420.
5. Carbone A, Gloghini A, Larocca LM, et al. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood. 2001;97:744-751.
6. Gatter KC, Warnke RA. Diffuse large B-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:171-174. World Health Organization Classification of Tumours.
7. Vega F, Chang CC, Medeiros LJ, et al. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol. 2005;18:806-815.
8. Greipp PR, Raymond NM, Kyle RA, et al. Multiple myeloma: significance of plasmablastic subtype in morphological classification. Blood. 1985;65:305-310.
9. Sailer M, Vykoupil KF, Peest D, et al. Prognostic relevance of a histologic classification system applied in bone marrow biopsies from patients with multiple myeloma: a histopathological evaluation of biopsies from 153 untreated patients. Eur J Haematol. 1995;54:137-146.
10. Tsai ST, Jin YT, Wu TC. Synthesis of PCR-derived, digoxigenin-labeled DNA probes for in situ detection of Epstein-Barr early RNAs in Epstein-Barr virus-infected cells. J Virol Methods. 1995;54:67-74.
11. Colomo L, Loong F, Rives S, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol. 2004;28:736-747.
12. Chuang SS, Ye H, Du MQ, et al. Histopathology and immunohistochemistry in distinguishing Burkitt lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without starry-sky pattern: a comparative study with EBER and FISH. Am J Clin Pathol. In press.
13. Aguilera NS, Kapadia SB, Nalesnik MA, et al. Extramedullary plasmacytoma of the head and neck: use of paraffin sections to assess clonality with in situ hybridization, growth fraction, and the presence of Epstein-Barr virus. Mod Pathol. 1995;8:503-508.
14. Tomita Y, Ohsawa M, Hashimoto M, et al. Plasmacytoma of the gastrointestinal tract in Korea: higher incidence than in Japan and Epstein-Barr virus association. Oncology. 1998;55:27-32.
15. Hsieh AT, Ho CL, Chen YC, et al. Epstein-Barr virus and lymphoid hematological disorders. Zonghua Yi Xue Za Zhi (Taipei). 2002;65:119-123.
16. Dupin N, Fisher C, Kellam P, et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A. 1999;96:4546-4551.
17. Dupin N, Diss TL, Kellam P, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood. 2000;95:1406-1412.
18. Gao SJ, Alsina M, Deng JH, et al. Antibodies to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in patients with multiple myeloma. J Infect Dis. 1998;178:846-849.
19. Brander C, Raje N, O'Connor PG, et al. Absence of biologically important Kaposi sarcoma-associated herpesvirus gene products and virus-specific cellular immune responses in multiple myeloma. Blood. 2002;100:698-700.
20. Tedeschi R, Luostarinen T, De Paoli P, et al. Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma risk. Br J Cancer. 2005;93:834-837.
21. Goedert JJ, Cote TR, Virgo P, et al. Spectrum of AIDS-associated malignant disorders. Lancet. 1998;351:1833-1839.
22. Cheung MC, Pantanowitz L, Dezube BJ. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy. Oncologist. 2005;10:412-426.
23. Dong HY, Scadden DT, de Leval L, et al. Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol. 2005;29:1633-1641.
24. Li CF, Ye H, Liu H, et al. Fatal HHV-8-associated hemophagocytic syndrome in an HIV-negative immunocompetent patient with plasmablastic variant of multicentric Castleman disease (plasmablastic microlymphoma). Am J Surg Pathol. 2006;30:123-127.
25. Fritz E, Ludwig H, Kundi M. Prognostic relevance of cellular morphology in multiple myeloma. Blood. 1984;63:1072-1079.
26. Carter A, Hocherman I, Linn S, et al. Prognostic significance of plasma cell morphology in multiple myeloma. Cancer. 1987;60:1060-1065.
27. Bartl R, Frisch B, Fateh-Moghadam A, et al. Histologic classification and staging of multiple myeloma: a retrospective and prospective study of 674 cases. Am J Clin Pathol. 1987;87:342-355.
28. Goasguen JE, Zandecki M, Mathiot C, et al. Mature plasma cells as indicator of better prognosis in multiple myeloma: new methodology for the assessment of plasma cell morphology. Leuk Res. 1999;23:1133-1140.
29. Bartl R, Frisch B, Burkhardt R, et al. Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging. Br J Haematol. 1982;51:361-375.